Allahabadi Sachin, Galivanche Anoop R, Coss Nathan, Tenzing Norbu, Gatto Andrew P, Murray Jerome C, Allahabadi Sameer, Pandya Nirav K
Department of Orthopaedic Surgery, University of California San Francisco, San Francisco, California, U.S.A.
School of Medicine, University of California San Francisco, San Francisco, California, U.S.A.
Arthrosc Sports Med Rehabil. 2023 Dec 21;6(1):100841. doi: 10.1016/j.asmr.2023.100841. eCollection 2024 Feb.
To perform a descriptive epidemiologic analysis of National Basketball Association (NBA) injuries from 2016 to 2021, to evaluate the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019, or COVID-19) on injury patterns and performance statistics, and to determine the effect of infection with SARS-CoV-2 on individual performance statistics.
Injury epidemiology in the NBA from the 2016 to 2021 seasons was collected using a comprehensive online search. Injuries and time missed were categorized by injury location and type. Player positions and timing of injury were recorded. Performance statistics were collected including traditional game statistics and Second Spectrum (speed, distance) statistics. Comparisons were made over seasons and comparing the pre-COVID-19 pandemic seasons to the pandemic era seasons. Players diagnosed with COVID-19 were analyzed for changes in performance in the short or long term.
Of the 3,040 injuries captured, 1,880 (61.84%) were in the lower extremity. Guards (77.44%) and forwards (75.88%) had a greater proportion of soft-tissue injuries ( < .001) than centers. Guards had the highest proportion of groin (3.27%, = .001) and hamstring (6.21%, < .001) injuries. Despite minor differences on a per-season basis, there were no differences in injury patterns identified between pre-COVID-19 and COVID-19 eras. Of players diagnosed with COVID-19 during the NBA Bubble, there were no detriments in short- or long-term performance identified, including traditional game statistics and speed and distance traveled.
In the NBA seasons from 2016 to 2021, most injuries were to the lower extremity. The SARS-CoV-2 pandemic did not substantially impact injury patterns in the NBA, including locations of injury and type of injury (bony or soft tissue). Furthermore, infection with SARS-CoV-2 does not appear to have a significant impact on performance in basketball-specific or speed and distance measures.
Level IV, prognostic case series.
对2016年至2021年美国职业篮球联赛(NBA)的伤病情况进行描述性流行病学分析,评估严重急性呼吸综合征冠状病毒2(SARS-CoV-2)(冠状病毒病2019,即COVID-19)对伤病模式和表现统计数据的影响,并确定感染SARS-CoV-2对个人表现统计数据的影响。
通过全面的在线搜索收集2016年至2021赛季NBA的伤病流行病学数据。伤病情况和缺阵时间按受伤部位和类型进行分类。记录球员位置和受伤时间。收集表现统计数据,包括传统比赛统计数据和Second Spectrum(速度、距离)统计数据。对各赛季进行比较,并将COVID-19大流行前的赛季与大流行时期的赛季进行比较。对被诊断为COVID-19的球员的短期或长期表现变化进行分析。
在记录的3040例伤病中,1880例(61.84%)发生在下肢。后卫(77.44%)和前锋(75.88%)的软组织伤病比例(<.001)高于中锋。后卫的腹股沟伤病比例最高(3.27%,=.001),腘绳肌伤病比例最高(6.21%,<.001)。尽管各赛季存在细微差异,但在COVID-19之前和COVID-19时期之间未发现伤病模式存在差异。在NBA复赛园区被诊断为COVID-19的球员中,未发现短期或长期表现有不利影响,包括传统比赛统计数据以及速度和行进距离。
在2016年至2021年的NBA赛季中,大多数伤病发生在下肢。SARS-CoV-2大流行并未对NBA的伤病模式产生重大影响,包括受伤部位和伤病类型(骨性或软组织)。此外,感染SARS-CoV-2似乎对篮球专项表现或速度和距离指标没有显著影响。
IV级,预后病例系列。